Study To Evaluate The Safety And Efficacy Of The MyEllevate® Procedure

Inclusion Criteria: * A healthy male or female between the age of 18 - 65. * Must have any or all the following: visible platysma bands, glands and/or sagging in the submentum, jawline and/or neck. * Reads and understands English. * Understands and accepts obligation not to receive any other procedures on the treatment area through the length of the study. * Understands and accepts the obligation and is logistically able to be present for all visits. * Is willing to comply with all requirements of the study and sign the informed consent document. Exclusion Criteria: Is pregnant or of childbearing potential and not using medically effective birth control, or has been pregnant in the last 3 months, currently breast feeding or planning a pregnancy during the study. * Is currently enrolled in an investigational drug or device trial, or has received an investigational drug or been treated with an investigational device within in the area to be treated 6 months (or at the discretion of the Investigator) prior to entering this study. * Have received any treatments or procedures (including injectables such as Botox or fillers) in the area to be treated at least 4 months prior to treatment. * Take antiplatelets, anticoagulants, thrombolytics, or anti-inflammatories. * Have an active localized or systemic infection. * Have an open wound in area being treated. * Have a significant systemic illness or an illness localized in area being treated. * Have had recent surgeries or problems in the treatment area (e.g. neck fracture, neck sprain, pinched nerve, spondylosis, arthritis in the neck). * Have a history of thrombophlebitis. * Have a history of heart failure or kidney disease. * Have a history of allergic reaction or intolerance to the anesthesia used during the procedure. * Have a history of poor wound healing. * Have a history of poor circulation. * Have a systemic autoimmune disease known to impair wound healing. * Have a history of keloid formation. * Currently enrolled in an investigational drug or device trial, or has received an investigational drug or been treated with an investigational device within the area to be treated 6 months (or at the discretion of the Investigator) prior to entering this study. * Has any condition or is in a situation which in the investigators opinion may put the subject at significant risk, may confound study results or may interfere significantly with the subject's participation.